Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90 GBX | +0.67% | -2.81% | +4.29% |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
17/04 | De La Rue says yearly profit to be in line with expectations | AN |
Sales 2024 * | 319M 399M 33.36B | Sales 2025 * | 354M 444M 37.06B | Capitalization | 176M 221M 18.44B |
---|---|---|---|---|---|
Net income 2024 * | -3M -3.76M -314M | Net income 2025 * | 11M 13.78M 1.15B | EV / Sales 2024 * | 0.86 x |
Net Debt 2024 * | 99.23M 124M 10.38B | Net Debt 2025 * | 92.42M 116M 9.67B | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
-44.6
x | P/E ratio 2025 * |
15.5
x | Employees | 1,841 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.73% |
Latest transcript on De La Rue plc
1 day | +0.67% | ||
1 week | -2.81% | ||
Current month | -4.26% | ||
1 month | +10.29% | ||
3 months | +2.04% | ||
6 months | +57.89% | ||
Current year | +4.29% |
Managers | Title | Age | Since |
---|---|---|---|
Clive Vacher
CEO | Chief Executive Officer | - | 07/19/07 |
Dean Moore
DFI | Director of Finance/CFO | 66 | 26/23/26 |
Ruth Euling
BRD | Director/Board Member | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Moore
DFI | Director of Finance/CFO | 66 | 26/23/26 |
Nicholas Bray
BRD | Director/Board Member | 59 | 21/16/21 |
Brian Small
BRD | Director/Board Member | 67 | 08/23/08 |
Date | Price | Change | Volume |
---|---|---|---|
10/24/10 | 90 | +0.67% | 250,118 |
09/24/09 | 89.4 | 0.00% | 50,012 |
08/24/08 | 89.4 | -2.83% | 674,939 |
07/24/07 | 92 | -0.65% | 122,459 |
Delayed Quote London S.E., May 10, 2024 at 09:05 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.29% | 221M | |
-6.63% | 7.59B | |
+8.88% | 2.22B | |
+180.00% | 1.21B | |
-38.99% | 1.16B | |
+5.92% | 1B | |
-13.78% | 913M | |
-6.97% | 623M | |
-6.39% | 531M | |
-9.81% | 471M |
- Stock Market
- Equities
- DLAR Stock